Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 1463 entries
View as:

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06092957 Org: User:
Start: 10/09/23 End: 10/30/31 Due: 10/30/32

A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04320992 Org: User:
Start: 03/31/20 End: 03/31/23 Due: 03/31/24

Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT02465749 Org: User:
Start: 05/31/15 End: 06/30/25 Due: 06/30/26

A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06233864 Org: User:
Start: 04/17/24 End: 04/17/26 Due: 04/17/27

A Platform for Multidisciplinary Medical Artificial Intelligence Development

Phase: N/A Priority: Normal
NCT ID: NCT04890847 Org: User:
Start: 03/18/21 End: 05/31/21 Due: 05/31/22

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC

Phase: N/A Priority: Normal
NCT ID: NCT01854203 Org: User:
Start: 07/31/13 End: 12/31/16 Due: 12/31/17

GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06455410 Org: User:
Start: 06/18/24 End: 06/18/28 Due: 06/18/29

Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03810339 Org: User:
Start: 01/15/19 End: 01/15/24 Due: 01/15/25

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

Phase: N/A Priority: Normal
NCT ID: NCT03830385 Org: User:
Start: 02/15/19 End: 02/15/26 Due: 02/15/27

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT04073784 Org: User:
Start: 06/08/19 End: 04/01/24 Due: 04/01/25

Efficacy of Enhanced External Counterpulsation on Ventricular Function

Phase: N/A Priority: Normal
NCT ID: NCT03106116 Org: User:
Start: 03/15/17 End: 03/30/19 Due: 03/30/20

Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

Phase: N/A Priority: Normal
NCT ID: NCT03500874 Org: User:
Start: 05/28/18 End: 08/31/21 Due: 08/31/22

The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04762745 Org: User:
Start: 02/28/21 End: 02/28/23 Due: 02/28/24

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

Phase: N/A Priority: Normal
NCT ID: NCT03245905 Org: User:
Start: 08/20/17 End: 12/31/21 Due: 12/31/22

MDR Bacilli Surveillance and Clinical Feature in China

Phase: N/A Priority: Normal
NCT ID: NCT02140853 Org: User:
Start: 11/30/11 End: 12/31/15 Due: 12/31/16

Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01271439 Org: User:
Start: 09/30/10 End: 12/31/12 Due: 12/31/13

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

Phase: N/A Priority: Normal
NCT ID: NCT02080234 Org: User:
Start: 03/31/14 End: 03/31/17 Due: 03/31/18

Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04539600 Org: User:
Start: 11/01/20 End: 12/12/22 Due: 12/12/23

Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04157491 Org: User:
Start: 10/18/19 End: 12/31/22 Due: 12/31/23

The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06472739 Org: User:
Start: 09/15/23 End: 11/15/24 Due: 11/15/25

Practical Pattern of Surgical Timing of Childhood Cataract in China

Phase: N/A Priority: Normal
NCT ID: NCT03640780 Org: User:
Start: 01/31/05 End: 12/31/14 Due: 12/31/15

A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06369597 Org: User:
Start: 04/15/24 End: 03/31/25 Due: 03/31/26

Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-

Phase: N/A Priority: Normal
NCT ID: NCT06895577 Org: User:
Start: 06/20/25 End: 12/31/25 Due: 12/31/26

Osteosclerotic Changes on CT Predict Survival in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06883474 Org: User:
Start: 07/01/10 End: 05/30/23 Due: 05/30/24

Trial of E10A in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00634595 Org: User:
Start: 03/31/08 End: 12/31/10 Due: 12/31/11